United States · Series A startup

Who invested in Protillion Biosciences

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 27 Oct 2026

$18Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $18MDec 2022
Investors
2
See who backed them

The rounds

  1. Dec 2022
    Series A$18M

    Source recorded

Founders and team

From Protillion Biosciences's own website: 3 founders, 13 on the team.

Curtis LaytonCEO/Co-Founder
David WaltCo-Founder
Will GreenleafCo-Founder
  • Robert HollingsworthChief Scientific Officer
  • Devin SullivanHead of Bioinformatics
  • Fedor TrintchoukHead of Hardware Engineering
  • Jacob GanoHead of Antibody Engineering
  • Mike BurrowsHead of Target Strategy
  • Pavan VaidyanathanHead of Platform Technology
  • Randy SchreckhiseHead of Finance and Operations
  • Brandon LatifiPlatform Scientist
  • Dan LeventhalBoard of Directors
  • Jonathan ParkinsonSenior Bioinformatics Scientist
  • Lydia FultonAssociate Scientist
  • Marjorie MaasController
  • Tarsus LamBioinformatics Associate Scientist

Everyone who backed them

Illumina VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Protillion Biosciences

Who invested in Protillion Biosciences?

Protillion Biosciences's investors include ARCH Venture Partners and Illumina Ventures.

How much has Protillion Biosciences raised?

Protillion Biosciences has raised $18M across 1 round since 2022.

When did Protillion Biosciences last raise?

Protillion Biosciences's most recent round was a Series A of $18M in Dec 2022.

What was Protillion Biosciences's biggest round?

Its most recent round, $18M in Dec 2022, is also its largest on record.

Who backed Protillion Biosciences first?

Protillion Biosciences's first round on record, in Dec 2022, was backed by ARCH Venture Partners and Illumina Ventures.

What stage is Protillion Biosciences at?

Protillion Biosciences's latest named round is a Series A, in Dec 2022.

Where is Protillion Biosciences based?

Protillion Biosciences is based in the United States.

Companies like Protillion Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.